Andreas Halvorsen’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,150,826
Closed -$250M 108
2024
Q1
$250M Hold
7,150,826
0.93% 34
2023
Q4
$272M Hold
7,150,826
1% 34
2023
Q3
$131M Buy
7,150,826
+511,627
+8% +$10.7M 0.53% 46
2023
Q2
$172M Hold
6,639,199
0.71% 46
2023
Q1
$125M Hold
6,639,199
0.59% 42
2022
Q4
$164M Buy
6,639,199
+1,333,333
+25% +$39.2M 0.82% 39
2022
Q3
$95.2M Hold
5,305,866
0.44% 58
2022
Q2
$60.2M Hold
5,305,866
0.28% 64
2022
Q1
$118M Hold
5,305,866
0.48% 55
2021
Q4
$232M Hold
5,305,866
0.67% 44
2021
Q3
$177M Hold
5,305,866
0.48% 58
2021
Q2
$146M Hold
5,305,866
0.44% 52
2021
Q1
$106M Hold
5,305,866
0.32% 65
2020
Q4
$175M Hold
5,305,866
0.48% 52
2020
Q3
$95.5M Buy
+5,305,866
New +$96.1M 0.35% 62

Other funds holding INBX

Andreas Halvorsen's INBX Position: Q2 2024 in Review

Andreas Halvorsen sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 7,150,826 shares — an estimated $250M sold.

Andreas Halvorsen first reported a position in INBX in Q3 2020 and held it in 15 quarters. The position peaked at $272M in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • Andreas Halvorsen reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Andreas Halvorsen sold 7,150,826 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $250M.
  • Andreas Halvorsen first reported a position in Inhibrx, Inc. Common Stock in Q3 2020 and held it in 15 quarters.
  • Andreas Halvorsen's Inhibrx, Inc. Common Stock position peaked at $272M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Viking Global Investors's 13F filing for Q2 2024, filed 14 Aug 2024.